Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Thierry Jo Molina, Danielle Canioni, Christiane Copie-Bergman, Christian Recher, MD, PhD, Marion Fournier, Corinne Haioun, Josette Briere, Francoise Berger, Christophe Fermé, Marie-Christine Copin, Rene-Olivier Casasnovas, Catherine Thieblemont, MD, Karen Leroy, Gilles Andre Salles, Fabrice Jardin, Jean-Philippe Jais, Philippe Gaulard, Bertrand Coiffier, Herve Tilly

Blood (2011) 118 (21): 2632.

https://doi.org/10.1182/blood.V118.21.2632.2632

Published: 2011

Journal Articles

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Judith Trotman, MBChB, FRACP, FRCPA, Marion Fournier, Thierry Lamy, MD, PhD, Jane A Estell, MBBS, FRCPA, FRACP, Anne Sonet, MD, Andrea Janikova, MD, PhD, Herve Tilly, Didier Decaudin, Jean Gabarre, MD, John F Seymour, MD, FRACP, Etienne Garin, Cecily Forsyth, Michael Fulham, MBBS, FRACP, Thierry Vander Borght, MD, PhD, Ofer Shpilberg, MD, MPH, Gilles Salles

Blood (2010) 116 (21): 855.

https://doi.org/10.1182/blood.V116.21.855.855

Published: 2010

Journal Articles

Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

David Sibon, MD, PhD, Marion Fournier, Josette Briere, MD, Laurence Lamant, MD, PhD, Corinne Haioun, MD, Bertrand Coiffier, MD, PhD, Serge Bologna, MD, Pierre Morel, MD, Jean Gabarre, MD, Olivier Hermine, MD, PhD, Anne Sonet, MD, Christian Gisselbrecht, MD, Georges Delsol, MD, Philippe Gaulard, MD, Herve Tilly, MD

Blood (2010) 116 (21): 322.

https://doi.org/10.1182/blood.V116.21.322.322

Published: 2010

Journal Articles

Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.

Richard Delarue, MD, Corinne Haioun, MD, Florence Broussais-Guillaumot, MD, David Sibon, MD, Marion Fournier, Nicolas Mounier, MD, Tony Petrella, MD, Serge Bologna, MD, Christophe Fruchart, MD, Christophe Ferme, MD, Christian Recher, MD, PhD, Stephanie Picard, Herve Tilly, MD, Andre Bosly, MD, PhD

Blood (2009) 114 (22): 1701.

https://doi.org/10.1182/blood.V114.22.1701.1701

Published: 2009

Journal Articles

R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study.

Richard Delarue, MD, Herve Tilly, MD, Gilles Salles, MD, PhD, Christian Gisselbrecht, MD, Nicolas Mounier, MD, Marion Fournier, Thierry Jo Molina, MD, Caroline Bonmati, MD, Hervé Ghesquieres, MD, Michel Blanc, MD, Delphine Germain, Laurence Girard, Corinne Haioun, MD, Andre Bosly, MD, PhD

Blood (2009) 114 (22): 406.

https://doi.org/10.1182/blood.V114.22.406.406

Published: 2009

Journal Articles

Autologous Stem Cell Transplantation (auto-SCT) as the Treatment of Choice for Follicular Lymphoma Patients in First Relapse: Final Analysis of the Outcome of 175 Patients Treated in the GELA/GOELAMS FL 2000 Study

Steven Le Gouill, MD, PhD, Sophie De Guibert, Christelle Volteau, Marion Fournier, Franck Morschhauser, Chantal Doyen, Pauline Brice, Corinne Haioun, Charles Foussard, Gilles Andre Salles, MD, PhD

Blood (2008) 112 (11): 773.

https://doi.org/10.1182/blood.V112.11.773.773

Published: 2008

Journal Articles

Cytokine Gene Polymorphisms and Outcome of Patients with Hodgkin Lymphoma: A Prospective Study of the Groupe D’Etude Des Lymphomes De L’Adulte

Herve Ghesquieres, MD, Olivier Casasnovas, MD, Marion Fournier, David Cox, MS, PhD, Pauline Brice, MD, Franck Morschhauser, MD, Anne-Laure Borrel, Catherine Sebban, MD, Vincent Ribrag, MD, Corinne Haioun, MD, PhD, Pierre Feugier, MD, Herve Tilly, MD, PhD, Christophe Ferme, MD, Gilles Andre Salles, MD, PhD

Blood (2008) 112 (11): 519.

https://doi.org/10.1182/blood.V112.11.519.519

Published: 2008

Journal Articles

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

Danielle Canioni, Gilles Salles, Nicolas Mounier, Nicole Brousse, Marie Keuppens, Frank Morchauser, Marion Fournier, Thierry Lamy, Marie-Christine Rousselet, Charles Foussard, Luc Xerri

Blood (2006) 108 (11): 822.

https://doi.org/10.1182/blood.V108.11.822.822

Published: 2006

NARROW

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Prognostic Factors and Long Term Outcome of 138 Adults with Systemic Anaplastic Large-Cell Lymphoma: a Retrospective Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.

R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study.

Autologous Stem Cell Transplantation (auto-SCT) as the Treatment of Choice for Follicular Lymphoma Patients in First Relapse: Final Analysis of the Outcome of 175 Patients Treated in the GELA/GOELAMS FL 2000 Study

Cytokine Gene Polymorphisms and Outcome of Patients with Hodgkin Lymphoma: A Prospective Study of the Groupe D’Etude Des Lymphomes De L’Adulte

The Poor Prognosis Value of High Intra-Tumoral Macrophages Counts in Follicular Lymphoma Patients Requires Selection of Appropriate Cut-Off and Can Be Circumvented by Rituximab Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only